Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus

Nutrition and Cancer

Volumn 36, Issue 1, 2000, Pages 7-13

  Moe, Gaile L ^a   Kristal, Alan R ^b,c   Levine, Douglas S ^d   Vaughan, Thomas L ^c   Reid, Brian J ^c  

^a SEATTLE PACIFIC UNIVERSITY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Astra Merck   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SELENIUM;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BARRETT ESOPHAGUS; CELL CYCLE; CELL PROLIFERATION; DIET; DNA CONTENT; ESOPHAGUS CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MINERAL INTAKE; SELENIUM DEFICIENCY; WEIGHT GAIN;

EID: 0034127034     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC3601_2     Document Type: Article

References (51)

1. Lagergren, J, Bergstrom, R, Lindgren, A, and Nyren, O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340, 925-831, 1999.
2. Phillips, RW, and Wong, RKH: Barrett's esophagus: natural history, incidence, etiology and complications. Gastroenterol Clin North Am 20, 791-816, 1991.
3. Spechler, SJ, and Goyal, RK: Barrett's esophagus. N Engl J Med 315, 362-371, 1986.
4. McDonald, WC, and McDonald, JB: Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 60, 1094-1098, 1987.
5. Blot, WJ, Devesa, SS, and Fraumeni, JF, Jr: Continuing climb in rates of esophageal adenocarcinoma: an update (letter). JAMA 270, 1320, 1993.
6. Levine, DS: Barrett's esophagus. Sci Med 1, 16-25, 1994.
7. Gammon, MD, Schoenberg, JB, Ahsan, H, Risch, HA, Vaughn, TL, et al.: Tobacco, alcohol and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. JNCI 89, 1277-1284, 1997.
8. Haggitt, RC: Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25, 982-993, 1994.
9. Reid, BJ, Haggitt, RC, Rubin, CE, and Rabinovitch, PS: Barrett's esophagus: correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93, 1-11, 1987.
10. Rabinovitch, PS, Reid, BJ, Haggitt, RC, Norwood, TH, and Rubin, CE: Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 60, 65-71, 1988.
11. Reid, BJ, Blount, PL, Rubin, CE, Levine, DS, Haggitt, RC, et al.: Flow cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 102, 1212-1219, 1992.
12. Reid, BJ, Sanchez, CA, Blount, PL, and Levine, DS: Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 105, 119-129, 1993.
13. Gimenez, A, Minguela, A, Parilla, P, Bermejo, J, Perez, D, et al.: Flow cytometric DNA analysis and p53 expression show a good correlation with histologic findings in patients with Barrett's esophagus. Cancer 83, 641-651, 1998.
14. Mirvish, S, Huang, Q, Chen, SC, Birt, DF, Clark, G, et al.: Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. Endoscopy 25, 627S-631S, 1993.
15. Clark, G, Smyrk, T, Mirvish, S, Anselmino, M, Yamashita, Y, et al.: Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1, 252-261, 1994.
16. Becker, DJ, Sinclair, J, Castell, DO, and Wu, WC: A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol 84, 782-786, 1989.
17. Nebel, OT, and Castell, DO: Inhibition of the lower esophageal sphincter by fat: a mechanism for fatty food intolerance. Gut 14, 270-274, 1973.
18. Nebel, OT, and Castell, DO: Kinetics of fat inhibition of the lower esophageal sphincter. Appl Physiol 35, 6-8, 1973.
19. Kitchin, LI, and Castell, DO: Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med 151, 448-454, 1991.
20. Mercer, CD, Wren, SF, DaCosta, LR, and Beck, IT: Gastroesophageal pressure gradients and lower esophageal sphincter pressures in severely obese patients (abstr). Gastroenterology 82, 1129, 1982.
21. Kabat, GC, Ng, SKC, and Wynder, EL: Tobacco, alcohol intake and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control 4, 123-132, 1993.
22. Brown, LM, Swanson, CA, Gridley, G, Swanson, GM, Schoenberg, JB, et al.: Adenocarcinoma of the esophagus: role of obesity and diet. JNCI 87, 104-109, 1995.
23. Vaughn, TL, Davis, S, Kristal, A, and Thomas, DB: Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma vs. squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4, 85-92, 1993.
24. Levine, DS, Haggitt, RC, Blount, PL, Rabinovitch, PS, Rusch, VW, et al.: An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105, 40-50, 1993.
25. Kristal, AR, Shattuck, AL, and Williams, A: Food frequency questionnaires for diet intervention research. In Proceedings of the 17th National Nutrient Databank Conference, 7-10 June 1992, Baltimore, MD. Washington, DC: Int Life Sci Inst, 1994, pp 110-125.
26. Schakel, SF, Sievert, YA, and Buzzard, IM: Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 88, 1268-1271, 1998.
27. Lee, W, Roberts, SM, and Labbe, RF: Ascorbic acid determination with an automated enzymatic procedure. Clin Chem 43, 154-157, 1997.
28. Bieri, JG, Tolliver, TJ, and Catigani, GL: Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high-pressure liquid chromatography. Am J Clin Nutr 32, 2143-2149, 1979.
29. Craft, NE, Wise, SA, and Soares, JH: Optimization of an isocratic high-performance liquid chromatographic separation of carotenoids. J Chromatogr 589, 171-176, 1992.
30. Epler, KS, Ziegler, RG, and Craft, NE: Liquid-chromatographic method for determination of carotenoids, retinol and tocopherols in human serum and in food. J Chromatogr 619, 37-48, 1993.
31. Alfthan, G, and Kumpulainen, J: Determination of selenium in small volumes of blood plasma and serum by electrothermal atomic absorption spectrometry. Anal Chim Acta 140, 221-227, 1982.
32. Siedel, J, Hagele, EO, Ziegenhom, J, and Wahlefeld, AW: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29, 1075-1080, 1983.
33. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. In Selected Methods of Clinical Chemistry, GR Cooper (ed). Washington, DC: Am Assoc Clin Chem, 1983, vol 10, pp 91-99.
34. Friedewald, WT, Levy, RI, and Fredrickson, DS: Estimation of the concentration of the low-density lipoprotein cholesterol without the use of the preparative ultracentrifuge (abstr). Clin Chem 18, 499-502, 1972.
35. Nowell, PC: The clonal evolution of tumor cell populations. Science 194, 23-28, 1976.
36. Kuczmarski, RJ, Flegal, KM, Campbell, SM, and Johnson, CL: Increasing prevalence of overweight among US adults. JAMA 272, 205-211, 1994.
37. Food and Nutrition Board: Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy Press, 1979.
38. 2/tetraploid) populations, and progressions to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci USA 93, 7081-7084, 1996.
39. Shackney, SE, Smith, CA, Miller, BW, Burholt, DR, Murtha, K, et al.: Model human solid tumors. Cancer Res 49, 3344-3354, 1989.
40. Wisen, O, and Johansson, C: Gastrointestinal function in obesity: motility, secretion and absorption following a test meal. Metabolism 42, 390-395, 1992.
41. Sasaki, H, Nagulesparan, M, Dubois, A, Samloff, IM, and Straus, E: Gastric function and obesity: gastric emptying, gastric acid secretion and plasma pepsinogen. Int J Obesity 8, 183-190, 1984.
42. Horowitz, M, Collins, PJ, Cook, DJ, Harding, PE, and Shearman, DJ: Abnormalities of gastric emptying in obese patients. Int J Obes 7, 415-421, 1983.
43. Maddox, A, Horowitz, M, Wishart, J, and Collins, P: Gastric and esophageal emptying in obesity. Scand J Gastroenterol 24, 593-598, 1989.
44. Ortiz-Hidalgo, C, De La Vega, G, and Aguirre-Garcia, J: The histopathology and biologic prognostic factors of Barrett's esophagus. J Clin Gastroenterol 26, 324-333, 1998.
45. Pennington, JA, and Young, BE: Total diet study nutritional elements, 1982-1989. J Am Diet Assoc 91, 179-183, 1991.
46. Thompson, JH, Wilson, A, Lu, J, Singh, M, Jiang, C, et al.: Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15, 183-186, 1994.
47. Lantear, J, Fleming, J, Wu, L, Webster, G, and Harrison, P: The selenium metabolite selenodiglutathione induces p53 and apoptosis. Carcinogenesis 15, 1378-1392, 1994.
48. Clark, LC, Combs, GF, Turnbull, BW, Slate, EH, Chalker, DK, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 276, 1957-1963, 1996.
49. Blot, WJ, Li, JY, Taylor, PR, Guo, W, Dawsey, S, et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. JNCI 85, 1483-1492, 1993.
50. Pietinen, P, Hartman, AM, Haapa, E, Rasanene, L, Haapakoski, J, et al.: Reproducibility and validity of dietary assessment instruments. II. A qualitative food frequency questionnaire. Am J Epidemiol 128, 667-676, 1988.
51. Hunter, DJ, Morris, JS, Chute, CG, Kushner, E, Colditz, GA, et al.: Predictors of selenium concentration in human toenails. Am J Epidemiol 132, 114-122, 1990.